Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis.
BACKGROUND
MicroRNAs (miRNAs), endogenous small noncoding RNAs regulating the activities of target mRNAs and cellular processes, are present in human plasma in a stable form. In this study, we investigated whether miRNAs are also stably present in synovial fluids and whether plasma and synovial fluid miRNAs could be biomarkers of rheumatoid arthritis (RA) and osteoarthritis (OA).


METHODS
We measured concentrations of miR-16, miR-132, miR-146a, miR-155 and miR-223 in synovial fluid from patients with RA and OA, and those in plasma from RA, OA and healthy controls (HCs) by quantitative reverse transcription-polymerase chain reaction. Furthermore, miRNAs in the conditioned medium of synovial tissues, monolayer fibroblast-like synoviocytes, and mononuclear cells were examined. Correlations between miRNAs and biomarkers or disease activities of RA were statistically examined.


RESULTS
Synovial fluid miRNAs were present and as stable as plasma miRNAs for storage at -20 degrees C and freeze-thawing from -20 degrees C to 4 degrees C. In RA and OA, synovial fluid concentrations of miR-16, miR-132, miR-146a, and miR-223 were significantly lower than their plasma concentrations, and there were no correlation between plasma and synovial fluid miRNAs. Interestingly, synovial tissues, fibroblast-like synoviocytes, and mononuclear cells secreted miRNAs in distinct patterns. The expression patterns of miRNAs in synovial fluid of OA were similar to miRNAs secreted by synovial tissues. Synovial fluid miRNAs of RA were likely to originate from synovial tissues and infiltrating cells. Plasma miR-132 of HC was significantly higher than that of RA or OA with high diagnosability. Synovial fluid concentrations of miR-16, miR-146a miR-155 and miR-223 of RA were significantly higher than those of OA. Plasma miRNAs or ratio of synovial fluid miRNAs to plasma miRNAs, including miR-16 and miR-146a, significantly correlated with tender joint counts and 28-joint Disease Activity Score.


CONCLUSIONS
Plasma miRNAs had distinct patterns from synovial fluid miRNAs, which appeared to originate from synovial tissue. Plasma miR-132 well differentiated HCs from patients with RA or OA, while synovial fluid miRNAs differentiated RA and OA. Furthermore, plasma miRNAs correlated with the disease activities of RA. Thus, synovial fluid and plasma miRNAs have potential as diagnostic biomarkers for RA and OA and as a tool for the analysis of their pathogenesis.
Murata
Koichi
K
Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo, Kyoto 606-8507, Japan.
Yoshitomi
Hiroyuki
H
Tanida
Shimei
S
Ishikawa
Masahiro
M
Nishitani
Kohei
K
Ito
Hiromu
H
Nakamura
Takashi
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000378:metabolism*; D015415:Biomarkers / Q000378:metabolism; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000378:metabolism*; D008875:Middle Aged; D010003:Osteoarthritis / Q000175:diagnosis* / Q000378:metabolism*; D012720:Severity of Illness Index; D013582:Synovial Fluid / Q000378:metabolism*; D013583:Synovial Membrane / Q000378:metabolism
D015415:Biomarkers; D035683:MicroRNAs; C547077:MIRN132 microRNA, human; C542542:MIRN146 microRNA, human; C524942:MIRN155 microRNA, human; C505362:MIRN16 microRNA, human; C525067:MIR223, human
Free Radic Biol Med. 2007 Jul 1;43(1):90-9
17561097
N Engl J Med. 2005 Oct 27;353(17):1793-801
16251535
Arthritis Res Ther. 2008;10(4):R101
18759964
Anal Biochem. 2006 Dec 15;359(2):268-70
17007808
Cell Res. 2008 Oct;18(10):997-1006
18766170
RNA. 2005 Nov;11(11):1737-44
16244135
DNA Cell Biol. 2007 Apr;26(4):219-25
17465888
Anal Biochem. 2009 Apr 15;387(2):303-14
19454234
Clin Chem. 2009 Nov;55(11):1944-9
19696117
Blood. 2008 Mar 15;111(6):3183-9
18187662
J Biochem. 2006 Jul;140(1):13-21
16877764
Int Immunol. 2005 Jul;17(7):879-87
15908444
Cell. 2001 Dec 28;107(7):823-6
11779458
Cytokine. 2009 Feb;45(2):58-69
19121586
Arthritis Rheum. 1986 Aug;29(8):1039-49
3741515
Cancer Res. 2004 Jun 1;64(11):3753-6
15172979
Arthritis Rheum. 2009 May;60(5):1294-304
19404929
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4402-7
19246379
Nat Rev Cancer. 2007 Nov;7(11):819-22
17914404
Arthritis Rheum. 2008 May;58(5):1284-92
18438844
Arthritis Rheum. 2009 Apr;60(4):1035-41
19333945
Science. 2004 Jan 2;303(5654):83-6
14657504
Nat Cell Biol. 2007 Jun;9(6):654-9
17486113
Arthritis Rheum. 1988 Mar;31(3):315-24
3358796
Cytokine. 2009 Aug;47(2):112-8
19535263
Cell. 2005 Jan 14;120(1):15-20
15652477
JAMA. 2008 Jan 30;299(4):425-36
18230780
BMC Res Notes. 2009 May 19;2:89
19454029
J Oncol. 2009;2009:950201
19639033
JAMA. 2007 May 2;297(17):1901-8
17473300
Clin Chem. 2008 Jun;54(6):943-4
18509012
Cell Metab. 2006 Feb;3(2):87-98
16459310
Arthritis Rheum. 2006 Dec;54(12):3809-14
17133577
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8
18663219
Cell. 2004 Jan 23;116(2):281-97
14744438
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6
16885212
Arthritis Rheum. 2008 Apr;58(4):1001-9
18383392
Gastroenterology. 2005 Jun;128(7):1796-804
15940614
J Cell Sci. 2000 Oct;113 Pt 19:3365-74
10984428